Literature DB >> 25065009

Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis.

Cosimo Bruni1, Serena Guiducci1, Silvia Bellando-Randone1, Gemma Lepri1, Francesca Braschi1, Ginevra Fiori1, Francesca Bartoli1, Francesca Peruzzi1, Jelena Blagojevic1, Marco Matucci-Cerinic2.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the presence of digital lesions in very early diagnosis of SSc (VEDOSS) patients and its possible association with internal organ involvement.
METHODS: One hundred and ten VEDOSS patients were investigated for the presence of digital ulcers (DUs), digital pitting scars, calcinosis, necrosis or gangrene, nailfold videocapillaroscopic abnormalities, disease-specific autoantibodies (ACA and anti-topo I) and internal organ involvement.
RESULTS: Four patients reported a history of digital pitting scars, while 25 patients presented an active DU or reported a history of DUs. In particular, 16 patients presented with active DUs (14/16 also reporting a history of previous DUs), while the other 9 patients reported a history of DUs only. A statistically significant association between DUs and oesophageal manometry alteration was found in the whole DU population, as well as in the history of DU and the presence of active DU with/without a history of DU subgroups (P < 0.01, P = 0.01 and P < 0.05, respectively). DUs were observed in VEDOSS patients with internal organ involvement but not in those without organ involvement.
CONCLUSION: DUs are already present in VEDOSS patients characterized by internal organ involvement, significantly correlating and associating with gastrointestinal involvement. DUs may be a sentinel sign for early organ involvement in VEDOSS patients.
© The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  digital ulcers; oesophageal involvement; very early systemic sclerosis

Mesh:

Year:  2014        PMID: 25065009     DOI: 10.1093/rheumatology/keu296

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  12 in total

Review 1.  Early systemic sclerosis-opportunities for treatment.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Christina Katsiari; Dimitrios Bogdanos; Ian C Chikanza
Journal:  Clin Rheumatol       Date:  2015-02-26       Impact factor: 2.980

Review 2.  Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.

Authors:  Silvia Bellando-Randone; Marco Matucci-Cerinic
Journal:  Curr Rheumatol Rep       Date:  2017-09-18       Impact factor: 4.592

3.  Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic.

Authors:  Enrico De Lorenzis; Gerlando Natalello; Lucrezia Verardi; Pier Giacomo Cerasuolo; Laura Gigante; Maria Antonietta D'Agostino; Silvia Laura Bosello
Journal:  Microvasc Res       Date:  2022-07-11       Impact factor: 3.750

4.  Long-term effects of immunosuppressive therapy on lung function in scleroderma patients.

Authors:  Slavica Pavlov-Dolijanovic; Nada Vujasinovic Stupar; Vladimir Zugic; Predrag Ostojic; Ana Zekovic; Tatjana Zivanovic Radnic; Ivan Jeremic; Ivana Tadic
Journal:  Clin Rheumatol       Date:  2018-08-24       Impact factor: 2.980

Review 5.  Points to consider for skin ulcers in systemic sclerosis.

Authors:  Felice Galluccio; Yannick Allanore; Lázló Czirjak; Daniel E Furst; Dinesh Khanna; Marco Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 6.  The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients.

Authors:  Barbara Ruaro; Marco Confalonieri; Francesco Salton; Barbara Wade; Elisa Baratella; Pietro Geri; Paola Confalonieri; Metka Kodric; Marco Biolo; Cosimo Bruni
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

7.  The "myth" of loss of angiogenesis in systemic sclerosis: a pivotal early pathogenetic process or just a late unavoidable event?

Authors:  Marco Matucci-Cerinic; Mirko Manetti; Cosimo Bruni; Ines Chora; Silvia Bellando-Randone; Gemma Lepri; Amato De Paulis; Serena Guiducci
Journal:  Arthritis Res Ther       Date:  2017-07-06       Impact factor: 5.156

Review 8.  Recognizing systemic sclerosis: comparative analysis of various sets of classification criteria.

Authors:  Katarzyna Romanowska-Próchnicka; Marcela Walczyk; Marzena Olesińska
Journal:  Reumatologia       Date:  2016-12-30

Review 9.  Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.

Authors:  May Y Choi; Marvin J Fritzler
Journal:  Curr Opin Rheumatol       Date:  2016-11       Impact factor: 5.006

10.  Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis?

Authors:  M Hughes; C Roberts; A Tracey; G Dinsdale; A Murray; A L Herrick
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-07-28       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.